9 Meters Biopharma Inc

NASDAQ:NMTR   9:48:20 AM EDT
1.08
-0.01 (-0.92%)
Products, Regulatory

9 Meters Biopharma Announces Positive Preclinical Data For NM-102, A Gut Microbiome Modulator In Immune Checkpoint Inhibitor Failure Model

Published: 11/16/2020 13:01 GMT
9 Meters Biopharma Inc (NMTR) - 9 Meters Biopharma Inc - Announces Positive Preclinical Data for Nm-102, a Gut Microbiome Modulator in an Immune Checkpoint Inhibitor Failure Model.
9 Meters Biopharma Inc - Intends to Move Forward With an Ind-enabling Pathway to Further Develop Nm-102.9 Meters Biopharma Inc - Nm-102 Shows Positive Effect in an Aggressive Immune Checkpoint Inhibitor Failure Melanoma Model.